Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Parekh

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Haematologica|October 9, 2025
Progressive multifocal leukoencephalopathy and BK virus-nephropathy with bispecific antibody therapy in multiple myelomaAriel Siegel, Sidorela Reci, Leah Grossman, et al.
Journal of Hematology & Oncology|August 17, 2022
Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutationMuhammad Elnaggar, Sarita Agte, Paula Restrepo, et al.
Blood Advances|October 9, 2024
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survivalZachary M Avigan, Saoirse Bodnar, Darren Pan, et al.
Blood Advances|August 22, 2025
SOX11 Modulates BCR Signaling Through the PAX5/CD19 Axis for Therapeutic Targeting in BTK Resistant Mantle Cell LymphomaRudra Prasad Dutta, Heng-Huan Lee, Violetta V Leshchenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple MyelomaWilliam E Pierceall, Michael D Amatangelo, Nizar J Bahlis, et al.
Journal of Hematology & Oncology|July 16, 2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forwardBo Wang, Oliver Van Oekelen, Tarek H Mouhieddine, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forwardBo Wang, Oliver Van Oekelen, Tarek H Mouhieddine, et al.
Bone Marrow Transplantation|October 19, 2022
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell supportTarek H Mouhieddine, Erin Moshier, Santiago Thibaud, et al.
Cell Reports. Medicine|May 22, 2024
Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myelomaMichael Amatangelo, Erin Flynt, Nicholas Stong, et al.
Nucleic Acids Research|July 18, 2013
Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancerSanchari Bhattacharyya, Yiting Yu, Masako Suzuki, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Haematologica|October 9, 2025
Progressive multifocal leukoencephalopathy and BK virus-nephropathy with bispecific antibody therapy in multiple myelomaAriel Siegel, Sidorela Reci, Leah Grossman, et al.
Journal of Hematology & Oncology|August 17, 2022
Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutationMuhammad Elnaggar, Sarita Agte, Paula Restrepo, et al.
Blood Advances|October 9, 2024
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survivalZachary M Avigan, Saoirse Bodnar, Darren Pan, et al.
Blood Advances|August 22, 2025
SOX11 Modulates BCR Signaling Through the PAX5/CD19 Axis for Therapeutic Targeting in BTK Resistant Mantle Cell LymphomaRudra Prasad Dutta, Heng-Huan Lee, Violetta V Leshchenko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple MyelomaWilliam E Pierceall, Michael D Amatangelo, Nizar J Bahlis, et al.
Journal of Hematology & Oncology|July 16, 2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forwardBo Wang, Oliver Van Oekelen, Tarek H Mouhieddine, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forwardBo Wang, Oliver Van Oekelen, Tarek H Mouhieddine, et al.
Bone Marrow Transplantation|October 19, 2022
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell supportTarek H Mouhieddine, Erin Moshier, Santiago Thibaud, et al.
Cell Reports. Medicine|May 22, 2024
Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myelomaMichael Amatangelo, Erin Flynt, Nicholas Stong, et al.
Nucleic Acids Research|July 18, 2013
Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancerSanchari Bhattacharyya, Yiting Yu, Masako Suzuki, et al.
Pageof 17